Stonebridge Financial Planning Group’s Boston Scientific BSX Stock Holding History

Stonebridge Financial Planning Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,126	Closed	-$573K	–	184
2026 Q1	$573K	Sell	9,126 -5,759	-39%	-$461K	0.21%	115
2025 Q4	$1.42M	Sell	14,885 -687	-4%	-$67.4K	0.51%	60
2025 Q3	$1.52M	Buy	15,572 +119	+0.8%	+$12.3K	0.57%	57
2025 Q2	$1.66M	Buy	15,453 +2,658	+21%	+$269K	0.69%	47
2025 Q1	$1.29M	Buy	12,795 +4,221	+49%	+$425K	0.59%	54
2024 Q4	$766K	Buy	8,574 +2,068	+32%	+$182K	0.34%	82
2024 Q3	$545K	Buy	+6,506	New	+$513K	0.26%	99

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stonebridge Financial Planning Group's BSX Position: Q2 2026 in Review

Stonebridge Financial Planning Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 9,126 shares — an estimated $573K sold.

Stonebridge Financial Planning Group first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $1.66M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Stonebridge Financial Planning Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Stonebridge Financial Planning Group sold 9,126 Boston Scientific shares in Q2 2026, an estimated $573K.
Stonebridge Financial Planning Group first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
Stonebridge Financial Planning Group's Boston Scientific position peaked at $1.66M in Q2 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stonebridge Financial Planning Group's 13F filing for Q2 2026, filed 31 Jul 2026.